Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP3 | P08254 | 1/20 | 0.31 |
| ▸ | MMP9 | P14780 | 1/20 | 0.31 |
| ▸ | MMP13 | P45452 | 1/20 | 0.31 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.31 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.30 |
| ▸ | THPO | P40225 | 1/20 | 0.30 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.30 |
| ▸ | LCK | P06239 | 1/20 | 0.30 |
| ▸ | FYN | P06241 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL8512781 | 0.97 | TSHR (0.36) | TSHRTP53CYP1A2GAACYP2C9 | |
| SCHEMBL9129538 | 0.81 | TSHR (0.39) | TSHRTHPO | |
| SCHEMBL9435536 | 0.81 | TP53 (0.38) | TSHRTP53CYP1A2GAACYP2C9 | |
| SCHEMBL526912 | 0.80 | TSHR (0.45) | TSHRTP53CYP1A2GAACYP2C9 | |
| SCHEMBL9842552 | 0.80 | TSHR (0.45) | TSHRTP53CYP1A2GAACYP2C9 | |
| Ammonia Solution, Strong SCHEMBL18138980 | 0.78 | TSHR (0.43) | TSHRTP53TDP1SLC7A5 | |
| Methyl Alcohol SCHEMBL28174876 | 0.78 | TSHR (0.43) | TSHRTP53TDP1SLC7A5 | |
| SCHEMBL140866 | 0.78 | — | — | |
| SCHEMBL140867 | 0.78 | — | — | |
| SCHEMBL1764859 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 208 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106111173-A | A kind of for being prepared the catalyst of pyruvate by lactate and preparing the method for pyruvate | 厦门市净屋环保科技有限公司 | 2016-11-16 | — | — | CN | claimed |
| US-20240238255-A1 | KL1333 FOR USE IN MEDICINE | YUNGJIN PHARM. CO., LTD (KR) | 2024-07-18 | — | — | US | disclosed |
| US-12012437-B2 | Methods of treating mitochondrial disorders | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-06-18 | — | — | US | disclosed |
| CN-114732007-B | Sperm cell process, apparatus and related media compositions | 英格朗公司 | 2024-04-12 | — | — | CN | disclosed |
| EP-4350323-A2 | SYSTEM FOR PREPARING AN OUTPUT SAMPLE COMPRISING A DEFINED CONCENTRATION OF AN INFECTIOUS AGENT FOR DOWNSTREAM TESTING | Avails Medical, Inc. (US) | 2024-04-10 | — | — | EP | disclosed |
| EP-3968021-B1 | SYSTEM FOR PREPARING AN OUTPUT SAMPLE COMPRISING A DEFINED CONCENTRATION OF AN INFECTIOUS AGENT FOR DOWNSTREAM TESTING | AVAILS MED INC (US) | 2024-04-03 | — | — | EP | disclosed |
| EP-4340831-A1 | KL1333 FOR USE IN MEDICINE | Abliva AB (SE) | 2024-03-27 | — | — | EP | disclosed |
| CN-117597429-A | Method and system for assessing the quality of flow dynamics in sperm-containing samples | 康奈尔大学 | 2024-02-23 | — | — | CN | disclosed |
| US-20240042440-A1 | METHODS FOR EVALUATING RHEOTAXIS QUALITY IN A SPERM-CONTAINING SAMPLE AND SYSTEMS THEREFOR | CORNELL UNIVERSITY | 2024-02-08 | — | — | US | disclosed |
| US-11857588-B2 | Reproductive cell maintenance system | MEMBRANE PROTECTIVE TECHNOLOGIES, INC. (US) | 2024-01-02 | — | — | US | disclosed |
| US-4450841-A | Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders | THOMAS JEFFERSON UNIVERSITY (US) | 1984-05-29 | — | — | US | disclosed |
| US-4451251-A | Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders | THOMAS JEFFERSON UNIVERSITY (US) | 1984-05-29 | — | — | US | disclosed |
| US-4445886-A | FLUOROCARBON EMULSION | THOMAS JEFFERSON UNIVERSITY (US) | 1984-05-01 | — | — | US | disclosed |
| US-4446154-A | Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders | THOMAS JEFFERSON UNIVERSITY (US) | 1984-05-01 | — | — | US | disclosed |
| US-4446155-A | Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders | THOMAS JEFFERSON UNIVERSITY (US) | 1984-05-01 | — | — | US | disclosed |
| US-4445500-A | Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders | THOMAS JEFFERSON UNIVERSITY (US) | 1984-05-01 | — | — | US | disclosed |
| US-4445888-A | FLUOROCARBON EMULSION | THOMAS JEFFERSON UNIVERSITY (US) | 1984-05-01 | — | — | US | disclosed |
| US-4445887-A | FLOROCARBON EMULSION | THOMAS JEFFERSON UNIVERSITY (US) | 1984-05-01 | — | — | US | disclosed |
| US-4353867-A | COMPUTERIZED QUANTITATIVE ANALYZER | LUZZANA MASSIMO | 1982-10-12 | — | — | US | disclosed |
| EP-0052718-A1 | Method and apparatus for the determination of substances in biological solutions by differential pH measurement | Luzzana, Massimo (IT) | 1982-06-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240238255-A1 | KL1333 FOR USE IN MEDICINE | CKMT1A; CKMT1B, SLC25A1, MT-ND3 | TSHR 2627/4885TP53 2722/4885CYP1A2 3882/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.